Delivery Order SPE2DB22D3004-SPE2DB26FQ69C
- Not listed
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) under a firm fixed-price contract valued at $6,065.50. The order was competitively awarded without a set-aside designation and carries an ultimate completion date of September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) under a firm fixed-price contract valued at $4,107.42. The award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $10,388.40 delivery order to AmerisourceBergen Drug Corp for Isotretinoin 30 mg capsules (10-count units) with a completion date of July 30, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $35,121.23 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) under a firm fixed-price contract valued at $4,335.66. The order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a small-value pharmaceutical procurement without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Isotretinoin 40 mg capsules (30-count packages) valued at $2,332.80, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,958.75 to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count packaging) on September 9, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Isotretinoin 30 mg capsules (30-count units) with a ceiling value of $7,051.35. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $1,226.11 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Isotretinoin 40 mg capsules (30-count packaging). This is a firm fixed price, non-set-aside contract with an ultimate completion date of June 2, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11.4K to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB26FQ69CDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Isotretinoin 30 mg capsules (30-count) under a firm fixed-price contract with a ceiling value of $8,110.07. The order was competitively awarded without set-aside designation and is scheduled for completion by October 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 million comprehensive pharmaceutical support vehicle valued through December 2026 that enables the contractor to supply a broad range of pharmaceuticals and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical requirements through competitive procurement, with delivery orders ranging from minimal to substantial values. Isotretinoin is a potent medication primarily used for severe acne treatment, and this order supports the pharmaceutical supply chain requirements of the Defense Logistics Agency's medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 10/20/25 |